INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322,574 | -59.8% | 829,238 | -53.9% | 0.00% | -50.0% |
| Q2 2023 | $802,914 | +21.8% | 1,798,240 | +325.6% | 0.00% | 0.0% |
| Q4 2022 | $659,139 | -79.9% | 422,525 | -77.7% | 0.00% | -81.8% |
| Q3 2022 | $3,275,000 | -58.7% | 1,898,394 | -58.5% | 0.01% | -57.7% |
| Q2 2022 | $7,923,000 | -5.6% | 4,579,636 | +95.8% | 0.03% | +4.0% |
| Q1 2022 | $8,395,000 | +1562.4% | 2,338,415 | +1428.3% | 0.02% | +1150.0% |
| Q4 2019 | $505,000 | +1385.3% | 153,006 | +820.3% | 0.00% | – |
| Q3 2019 | $34,000 | -90.5% | 16,625 | -86.3% | 0.00% | -100.0% |
| Q2 2019 | $357,000 | -28.7% | 121,381 | -9.7% | 0.00% | -50.0% |
| Q1 2019 | $501,000 | -28.4% | 134,368 | -23.2% | 0.00% | -33.3% |
| Q4 2018 | $700,000 | -16.4% | 175,059 | +16.3% | 0.00% | +50.0% |
| Q3 2018 | $837,000 | +754.1% | 150,482 | +498.9% | 0.00% | – |
| Q2 2018 | $98,000 | – | 25,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |